Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.44%176.32M | -3.17%1.14B | -16.93%265.14M | 20.13%400.79M | -11.29%253.21M | -7.64%218.87M | 22.05%1.18B | 13.45%319.18M | 17.32%333.63M | 40.58%285.43M |
| Net income from continuing operations | -13.13%93.1M | -3.49%341.79M | -4.44%81.69M | -3.97%73.3M | -17.53%79.64M | 11.91%107.16M | -15.27%354.13M | -6.88%85.48M | -24.82%76.33M | -7.39%96.56M |
| Operating gains losses | 99.61%-55K | -142.38%-5.6M | 218.83%3M | 266.44%9.7M | -83.27%-4.04M | -193.19%-14.25M | 180.55%13.21M | -176.87%-2.52M | 378.53%2.65M | -1,495.57%-2.21M |
| Depreciation and amortization | -2.17%172.08M | 6.10%714.65M | -4.82%173.58M | 8.28%182.25M | 11.75%182.92M | 10.49%175.9M | 8.56%673.56M | 16.95%182.36M | 8.56%168.31M | 6.15%163.68M |
| Asset impairment expenditure | ---- | -89.41%1.57M | --0 | --1.57M | ---- | ---- | --14.86M | --14.86M | --0 | ---- |
| Remuneration paid in stock | -32.70%1.5M | -29.75%5.93M | -21.44%1.56M | -34.00%2.32M | -106.61%-165K | 388.57%2.22M | 26.51%8.44M | -4.16%1.98M | 109.99%3.51M | 57.04%2.5M |
| Deferred tax | -3.44%25.71M | 40.08%87.33M | 15.74%17.62M | 80.19%20.18M | 28.53%22.9M | 47.12%26.63M | -34.21%62.34M | -15.97%15.23M | -43.99%11.2M | -27.83%17.82M |
| Other non cashItems | -1.50%62.54M | -0.92%262.06M | 2.44%66.72M | 7.40%65.91M | -5.79%65.94M | -6.62%63.49M | 6.87%264.49M | -3.79%65.13M | -4.62%61.37M | 14.83%69.99M |
| Change In working capital | -24.63%-92.44M | -88.77%6.33M | -95.61%1.53M | 34.74%103.32M | -980.47%-24.34M | -40.12%-74.17M | 157.61%56.37M | 250.67%34.88M | 192.24%76.68M | 96.76%-2.25M |
| -Change in receivables | -5.53%-10.76M | -284.25%-17.71M | -486.03%-16.7M | 103.59%26.06M | -243.77%-16.87M | -323.11%-10.19M | 272.78%9.61M | -175.91%-2.85M | -36.41%12.8M | 76.82%-4.91M |
| -Change in prepaid assets | -103.81%-12.67M | -347.92%-7.32M | -42.37%1.44M | -90.19%841K | -173.88%-3.39M | 51.09%-6.21M | 249.72%2.95M | -8.42%2.5M | -6.16%8.57M | 677.93%4.58M |
| -Change in payables and accrued expense | -61.97%-46.43M | 39.99%65.67M | -19.93%28.34M | 109.27%77.73M | -339.36%-11.74M | 6.11%-28.66M | 173.69%46.91M | 240.40%35.39M | 706.75%37.14M | 109.99%4.9M |
| -Change in other current assets | -65.23%-8.99M | 20.34%-21.63M | -6.62%-7.43M | 23.43%-5.47M | 36.62%-3.3M | 30.65%-5.44M | -3.62%-27.15M | 26.05%-6.96M | -7.47%-7.14M | 16.41%-5.2M |
| -Change in other working capital | 42.51%-13.6M | -152.76%-12.69M | -160.74%-4.13M | -83.58%4.16M | 771.24%10.95M | -268.30%-23.66M | 5,385.27%24.05M | 174.00%6.8M | 2,671.75%25.31M | -126.06%-1.63M |
| Interest paid (cash flow from operating activities) | 6.37%-57.55M | -0.91%-268.9M | -5.13%-75.38M | -11.76%-69.86M | 8.92%-62.2M | 3.91%-61.47M | -11.19%-266.46M | -9.48%-71.7M | 1.30%-62.51M | -35.69%-68.29M |
| Tax refund paid | -329.94%-28.54M | -25.04%-7.15M | 20.78%-5.17M | 408.86%12.1M | -197.57%-7.44M | -128.69%-6.64M | 93.76%-5.72M | -222.27%-6.53M | 80.58%-3.92M | 133.37%7.63M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -19.44%176.32M | -3.17%1.14B | -16.93%265.14M | 20.13%400.79M | -11.29%253.21M | -7.64%218.87M | 22.05%1.18B | 13.45%319.18M | 17.32%333.63M | 40.58%285.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -15.81%-158.62M | 36.36%-583.37M | -1.29%-159.73M | 61.81%-126.46M | 41.66%-160.21M | 10.55%-136.97M | 3.97%-916.61M | 22.79%-157.69M | 3.63%-331.17M | -59.39%-274.64M |
| Net PPE purchase and sale | -16.69%-155.94M | 12.64%-572.83M | -2.18%-157.02M | 27.27%-123.75M | 11.29%-158.44M | 12.83%-133.63M | 18.05%-655.71M | 24.87%-153.67M | 9.82%-170.15M | -3.54%-178.6M |
| Net intangibles purchas and sale | 18.57%-2.87M | 93.91%-12.38M | 27.37%-2.9M | 98.20%-2.91M | 91.98%-3.05M | ---3.52M | -238.70%-203.22M | ---3.99M | -168.62%-161.17M | ---38.06M |
| Net business purchase and sale | ---- | 101.87%1.09M | --0 | --0 | 101.88%1.09M | ---- | 41.24%-58.19M | -286.21%-216K | --0 | ---57.97M |
| Net other investing changes | 0.53%188K | 46.99%757K | 2.16%189K | 25.33%188K | --193K | 3.89%187K | -89.12%515K | 2.21%185K | -96.42%150K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -15.81%-158.62M | 36.36%-583.37M | -1.29%-159.73M | 61.81%-126.46M | 41.66%-160.21M | 10.55%-136.97M | 3.97%-916.61M | 22.79%-157.69M | 3.63%-331.17M | -59.39%-274.64M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 59.20%-28.26M | -1.88%-552.55M | -100.18%-274.68M | -447.50%-162.24M | -232.79%-46.36M | 80.84%-69.28M | -2,181.76%-542.37M | -75.50%-137.22M | -141.74%-29.63M | 84.04%-13.93M |
| Net issuance payments of debt | 169.19%23.19M | -42.93%-386.24M | -117.92%-221.4M | -1,887.60%-123.22M | -105.53%-8.11M | 89.60%-33.51M | -224.07%-270.24M | -131.49%-101.6M | -93.31%6.89M | 1,340.59%146.67M |
| Net common stock issuance | --0 | 102.84%3.3M | -101.85%-97K | --34K | 100.04%45K | 1,355.50%2.91M | -19.19%-116.06M | -11.05%5.24M | --0 | -85.31%-116.5M |
| Cash dividends paid | -7.04%-41.4M | -6.60%-154.72M | -8.02%-38.63M | -8.24%-38.71M | -8.03%-38.71M | -2.33%-38.67M | -5.20%-145.15M | -4.27%-35.76M | -4.27%-35.76M | -4.57%-35.83M |
| Proceeds from stock option exercised by employees | ---10.06M | 108.18%409K | ---- | ---- | ---- | --0 | 15.06%-5M | ---- | ---- | ---- |
| Net other financing activities | ---- | -158.36%-15.31M | -15,818.09%-14.96M | 55.24%-342K | 104.95%409K | ---- | -1,652.66%-5.92M | ---94K | ---764K | -2,345.86%-8.27M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 59.20%-28.26M | -1.88%-552.55M | -100.18%-274.68M | -447.50%-162.24M | -232.79%-46.36M | 80.84%-69.28M | -2,181.76%-542.37M | -75.50%-137.22M | -141.74%-29.63M | 84.04%-13.93M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.55%75.15M | -78.97%76.34M | 350.98%244.75M | 73.76%141.07M | 8.29%91.57M | -78.97%76.34M | -2.15%362.92M | -85.13%54.27M | -77.00%81.19M | -79.26%84.56M |
| Current changes in cash | -183.64%-10.56M | 100.74%2.09M | -797.44%-169.27M | 512.49%112.09M | 1,589.21%46.64M | 104.55%12.63M | -1,750.30%-283.76M | 2,314.42%24.27M | -331.27%-27.17M | 94.46%-3.13M |
| Effect of exchange rate changes | -79.42%537K | -15.90%-3.27M | 85.04%-330K | -3,399.61%-8.41M | 1,292.50%2.86M | 512.16%2.61M | -138.38%-2.82M | -162.62%-2.21M | 355.36%255K | -112.99%-240K |
| End cash Position | -28.87%65.13M | -1.55%75.15M | -1.55%75.15M | 350.98%244.75M | 73.76%141.07M | 8.29%91.57M | -78.97%76.34M | -78.97%76.34M | -85.13%54.27M | -77.00%81.19M |
| Free cash from | -73.75%16.3M | 69.21%529.46M | -34.99%104.62M | 19,011.03%271.95M | 35.25%90.79M | -25.57%62.1M | 212.67%312.91M | 112.42%160.92M | -95.90%1.42M | 123.20%67.13M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.